3 withdrawn. 3 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Withdrawn 3 |
| Phase 2 | 2 | Withdrawn 2 |
Follow Atrophy: new trials by email Literature Review of Atrophy trials Research Report on Atrophy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Mesenchymal Stem Cells for Age-Related Frailty Mesenchymal Stem Cells (MSCs) - Frailty | Phase 1 / Phase 2 | Withdrawn | VA Office of Research and Development | 2023-01-31 | 2023-02-06 | |
| Redefining Survivorship: POWER to Maximize Physical Function for Survivors of Critical Illness Power training - Critical Illness, Muscle Atrophy or Weakness | Phase 1 / Phase 2 | Withdrawn | Kirby Mayer | 2021-12-01 | 2020-10-28 | |
| A Clinical Study to Assess the Effects of SRT2104 Upon Immobilization-Induced Skeletal Muscle Atrophy in Healthy Human Volunteers Placebo, SRT2104 - Healthy Volunteer, Atrophy, Muscular | Phase 1 | Withdrawn | GlaxoSmithKline | 2011-01-01 | 2015-04-17 |
Muscular Atrophy (2) · Asthenia (1) · Critical Illness (1) · Frailty (1) · Osteoporosis (1) · Sarcopenia (1)
Nervous System Diseases (3) · Neurologic Manifestations (3) · Neuromuscular Manifestations (3) · Pathological Conditions, Anatomical (3) · Pathological Conditions, Signs and Symptoms (3) · Signs and Symptoms (3) · Pathologic Processes (2) · Bone Diseases (1) · Bone Diseases, Metabolic (1) · Disease Attributes (1) · Metabolic Diseases (1) · Muscular Atrophy (1) · Musculoskeletal Diseases (1) · Nutritional and Metabolic Diseases (1)
SRT2104 (1)
GlaxoSmithKline (1) · Kirby Mayer (1) · VA Office of Research and Development (1)
United States (2)
Dennis T Villareal, MD (1) · Kirby P Mayer, DPT (1)